Hiranis Logo
Home | Contact Us | Email 
    About 
Hiranis Pharma 
Marketing & 
Sales 
Technical 
Operations 
Distribution 
Network 
Products 
Home  >>  Products  >>  Nexbon
  NEXBON
 Therapeutic Segment
 -
 Generic
 Alfacalcidol
 Forms
 Tablets
 Strength
 Tablets : 0.25mcg / 0.50mcg
 Indications
 NEXBON (Alfacalcidol) is indicated in the diseases that
 resulted from distributed calcium metabolism due to
 decreased endogenous production of
 1,25-dihydroxyvitamin D3. Main indications are:
 Osteoporosis
 Renal Osteodystrophy
 Post-operative or Idiopathic hypoparathyroidism
 Pseudohypoparathyroidism
 Osteomalacia
 Vitamin D resistant rickets
 Malabsorptive and nutritional rickets
  Back









  Hiranis Logo Sitemap | Terms of use | Privacy Policy Copyright © 2014 Hiranis Pharmaceuticals Pvt. Ltd. All rights reserved. This information is intended for residents of Pakistan. The product information provided on the website relates to Products listed in Pakistan. Hiranis pharmaceutical company committed to helping people improve their health by discovering and developing innovative medicines.